Khan Shirani, MD
Undersea and Hyperbaric Medicine · San Antonio, TXNPI 1518135904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 25.4% of the total. 2025 is the largest year on record at $356, more than ten times the $12 reported in 2019. That places this record below the midpoint for undersea and hyperbaric medicine clinicians in TX, where the typical reported total is $844.
Across 39 payments — averaging $24.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$242
- Kerecis Limited$167
- Phathom Pharmaceuticals, Inc.$125
- Organogenesis Inc.$119
- Smith+Nephew$46
- Acera Surgical, Inc.$34
- plus $220 from 12 others
What the payments were for
- Food & beverage$953100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $242 |
| Kerecis Limited | 2 | $167 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Organogenesis Inc. | 4 | $119 |
| Smith+Nephew | 3 | $46 |
| Acera Surgical, Inc. | 2 | $34 |
| KCI USA, Inc. | 1 | $25 |
| Melinta Therapeutics, LLC | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Next Science LLC | 1 | $23 |
| Coloplast | 1 | $21 |
| Hartmann USA, Inc. | 1 | $19 |
| Medline Industries LP | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $16 |
| Cashflow Solutions, LLC | 2 | $16 |
| Convatec Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Hydrofera LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$600
- Kerecis GraftGuide$150
- VOQUEZNA$125
How this compares
$953 in reported general payments places this provider in the 50th percentile of 59 undersea and hyperbaric medicine providers in Texas.
See all undersea and hyperbaric medicine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 13 | $665 |
| SsdSilver Sulfadiazine | 15 | $408 |
| Mupirocin | 34 | $269 |
| Ciprofloxacin Hcl | 11 | $125 |
| Triamcinolone Acetonide | 15 | $81 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in San Antonio
- Heather AguirreSan Antonio$98K
- Jayesh ShahSan Antonio$17K
- Heather McKenzieSan Antonio$6K
- Manjulatha BadamSan Antonio$1K
- Fernando KarstSan Antonio$1K
- Jason KellySan Antonio$632
- Homer ReyesSan Antonio$291
- Jerry KelleySan Antonio$130
- Robert DunnSan Antonio$23
- Merritt Davis JrSan Antonio$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.